A look back at some of the more interesting stories from the junior market this past week.
By Calum Muirhead
Cancer drug developer Faron Pharmaceuticals Oy (LON:FARN) has been on a tear, with the share price up 350% in the year to date.
The momentum continued this week as the stock rose 60% to 240p on news of a £7.5 million cash injection that will help the group finance a clinical trial of its new drug Clevegen.
Clevegen has been designed to recognise cancer and break the cell’s protective shell. Ultimately, if it is successful, this new breed of treatment could be used in combination with PD-1 inhibitors, another treatment method, to tackle the killer disease.
Faron’s boss, CEO Markku Jalkanen, said the trial will allow the firm to “clarify [the] full potential” of Clevegen, with a view of sharing that data with the US Food and Drug Administration (FDA), which approves drugs for the American market.
The AIM All-Share was up 0.4% at 894 in the week, while the FTSE 100 rose 1.1% to 7,380.
Turning to the mining sector, Amur Minerals Corporation (LON:AMC) received a welcome boost in the form of new funding this week after a £1.2 million investment from an unnamed asset manager sent the shares up 62% to 3p.
Investors also took a shine to KEFI Minerals PLC (LON:KEFI), which surged 52% higher to 1.2p after it resolved several administrative roadblocks with the Ethiopian government regarding its Tulu Kapi gold project.
State administrative arrangements had held up the closing of project financing past the originally set date of 31 October, but the gold explorer and developer said the project can now proceed.
Planet Zoo’s launch, which saw it hit the number-one bestseller spot on gaming platform Steam, coincided with an announcement that Frontier’s new publishing arm, which has already signed two partnerships with third-party development partners to work on new games, is discussing more deals.
The announcement represents somewhat of a turnaround for the group, which saw its share price dive back in January when it posted a loss of £2.54mln for the year to 30 September.
The new products include HydroX-Cell(L) and HydroX-Cell(S), zero-emission fuel cells that use hydrogen to generate power.
The company is an investor in the Gainsborough Trough, a fracking project in the East Midlands whose future is now in doubt following the government’s decision.
LightwaveRF PLC (LON:LWRF) saw its share price dim considerably, falling 32% to 4.2p after it warned that its fourth-quarter revenues will be significantly below market expectations while losses were predicted to be higher than forecast.
Article originally published by proactive investors. Share Talk is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All investments can fall in value so you could get back less than you invest.
The above has been published by Proactive Investors Limited (the “Company”) on its website and is made available subject to the terms and conditions of use of its website (see T&C )
All copyrights @proactive_UK
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned